Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/29/1992 | WO1992008708A1 Biologically active amines |
05/29/1992 | WO1992008701A1 Retroviral protease inhibitors |
05/29/1992 | WO1992008700A1 Retroviral protease inhibitors |
05/29/1992 | WO1992008699A1 Retroviral protease inhibitors |
05/29/1992 | WO1992008698A1 Retroviral protease inhibitors |
05/29/1992 | WO1992008694A1 Aminosulfonyl urea acat inhibitors |
05/29/1992 | WO1992008693A1 Aminosulfonyl carbamates |
05/29/1992 | WO1992008692A1 Oxysulfonyl urea acat inhibitors |
05/29/1992 | WO1992008688A1 Retroviral protease inhibitors |
05/29/1992 | WO1992008474A2 Treatment of lung diseases |
05/29/1992 | WO1992008469A1 Method of reducing weight in mammals |
05/29/1992 | WO1992008468A1 Combinations of anthelmintically active agents |
05/29/1992 | WO1992008467A1 Dispersion preparation |
05/29/1992 | WO1992008466A1 Heparan sulfate biosynthesis primers |
05/29/1992 | WO1992008465A2 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
05/29/1992 | WO1992008464A1 Substituted urea and related cell adhesion modulation compounds |
05/29/1992 | WO1992008463A1 Direct compression method for preparing pills having cephalosporanic acid derivatives |
05/29/1992 | WO1992008460A1 Bis-dioxopiperazines for treating liver tumours |
05/29/1992 | WO1992008459A1 Topical compositions for transdermal delivery of produg derivatives of morphine |
05/29/1992 | WO1992008458A1 Use of temocillin or carbenicillin for the treatment or prophylaxis of bacterial infections in fish |
05/29/1992 | WO1992008452A1 Use of nabumetone for the treatment of myofascial pain syndrome |
05/29/1992 | WO1992008451A1 Use of nabumetone for treatment of cancer pain |
05/29/1992 | WO1992008450A2 ANTIVIRAL USE OF A 2,6-DI-t-BUTYLPHENOL COMPOUND SUBSTITUTED IN POSITION 4, PARTICULARLY IN RELATION TO HERPESVIRUSES AND PAPILLOMAVIRUSES |
05/29/1992 | WO1992008447A1 Aerosol containing medicaments |
05/29/1992 | WO1992008446A1 Aerosol medicaments |
05/29/1992 | WO1992008442A1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and anti-microbial agent |
05/29/1992 | WO1992008441A1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts |
05/29/1992 | WO1992005172A3 Muscarinic receptor antagonists |
05/29/1992 | CA2095430A1 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
05/29/1992 | CA2094807A1 Aminosulfonyl carbamates |
05/29/1992 | CA2074729A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
05/29/1992 | CA2056311A1 .beta.-hydroxyethylamines having a 1,1-disubstituted cyclopropyl radical,a p process for their preparation and their use |
05/29/1992 | CA2056144A1 Pharmaceutical compounds |
05/29/1992 | CA2056103A1 3-substituted cephalosporins, process for their preparation and their use as medicaments |
05/29/1992 | CA2055530A1 Aryl derivatives |
05/28/1992 | WO1992009618A1 8-ENE-19, 11β-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM |
05/28/1992 | WO1992009606A1 Optically active thiazoloisoindolinone derivatives with an antiviral action |
05/28/1992 | WO1992009287A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections |
05/28/1992 | WO1992009286A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
05/28/1992 | CA2097087A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections |
05/28/1992 | CA2097079A1 8-ene-19, 11.bet.beta.-bridged steroids, their preparation and pharma ceutical formulations containing them |
05/28/1992 | CA2096962A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
05/28/1992 | CA2095255A1 Optically-active thiazoloisoindolinone derivatives with anti-viral action |
05/27/1992 | WO1992009635A1 Methyl pyrrolidinone chitosan, production process and uses thereof |
05/27/1992 | WO1992009572A1 Anilide derivative |
05/27/1992 | WO1992009283A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
05/27/1992 | WO1992009269A1 Oral spiramycine formulations and method for preparing same |
05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
05/27/1992 | EP0487502A2 Pharmaceutically active aryl-substituted amine derivatives |
05/27/1992 | EP0487423A1 Benzoselenazolinone derivatives, their preparation and pharmaceutical compositions containing them |
05/27/1992 | EP0487411A1 Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments |
05/27/1992 | EP0487408A1 Oxazolopyridine derivatives, process for their preparation and pharmaceutical compositions comprising the same |
05/27/1992 | EP0487404A1 External dermatological composition |
05/27/1992 | EP0487382A1 Use of buflomedil for the protection of the myocardium by coronary angioplasty |
05/27/1992 | EP0487335A1 Pharmaceutical dosage forms of dihydropyridines |
05/27/1992 | EP0487270A2 HIV protease inhibitors having polyether substituents |
05/27/1992 | EP0487252A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
05/27/1992 | EP0487207A1 Benzolactam analogs as antagonists of CCK |
05/27/1992 | EP0487097A1 Pyrazoloacridone derivatives |
05/27/1992 | EP0487095A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation |
05/27/1992 | EP0487071A1 Condensed heterocyclic compounds, their production and use |
05/27/1992 | EP0487066A1 Disinfectant composition |
05/27/1992 | EP0486998A1 Slow-releasing composition of platinum-containing anticancer agent |
05/27/1992 | EP0486964A2 S(+)-Phenyl-alkanoic acids and alpha-hydroxy-alkanoic acids containing complexes |
05/27/1992 | EP0486959A1 Pharmaceutical composition of microparticles with controlled release and process of preparing it |
05/27/1992 | EP0486958A1 Physostigmine derivatives |
05/27/1992 | EP0486948A2 Retroviral protease inhibiting compounds |
05/27/1992 | EP0486944A2 Method of inhibiting tumor growth using xanthocillin X dimethylether |
05/27/1992 | EP0486882A1 Substituted anilides |
05/27/1992 | EP0486863A1 Antiacid compositions with prolonged gastric residence time |
05/27/1992 | EP0486809A2 Use of suramin against TNF-related diseases |
05/27/1992 | EP0486806A1 Process for the preparation of racemic pilosinine derivatives |
05/27/1992 | EP0486734A1 1-Aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
05/27/1992 | EP0486702A1 Phenyl 4-guanidinobenzoate derivative, process for producing the same, and protease inhibitor containing the same |
05/27/1992 | EP0486671A1 Orally active nonaddicting analgesics |
05/27/1992 | EP0486632A1 Anti-actinic agent. |
05/27/1992 | EP0486561A1 Buccal composition containing s(+) flurbiprofen or ketoprofen. |
05/27/1992 | EP0486529A1 Transdermal nitroglycerin patch with penetration enhancers |
05/27/1992 | EP0486499A1 Stable ascorbic acid compositions. |
05/27/1992 | DE4124333A1 Agent to inhibit inflammation and promote epithelial growth in eyes |
05/27/1992 | DE4037941A1 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentanetherderivate, processes for their preparation and their pharmaceutical use |
05/27/1992 | DE4037174A1 Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten New sulfonamides, process for their production and pharmaceuticals containing these compounds |
05/27/1992 | CN1061415A Complexes containing s(+) phenyl alkane acids and amino sugars |
05/27/1992 | CN1061414A Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
05/27/1992 | CN1061413A Pharmaceutical compounds |
05/27/1992 | CN1061411A Quinazolines derivatives for enhancing antitumor |
05/27/1992 | CN1061410A Substituted azoles, process for their preparation, agents containing them and their use |
05/27/1992 | CN1061409A Compounds, pharmaceutical compositions containing them and process for preparing same |
05/27/1992 | CN1061408A Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
05/27/1992 | CN1061407A Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
05/27/1992 | CN1061405A Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids |
05/27/1992 | CN1061404A Complexes containing s(+) phenyl alkane acids and alpha-amino acids |
05/27/1992 | CN1061341A Use of thiazoloisoindolinone derivatives as antiviral medicaments |
05/27/1992 | CN1061340A Semduramicin premix |
05/27/1992 | CN1016785B Azithromycin dihydrate |
05/27/1992 | CN1016784B Process for preparating homodisaccharide hypoglycemic agents |
05/27/1992 | CN1016783B Promoting agent of activity of some antitumor agent against various kinds of tumor cell |
05/27/1992 | CN1016782B Process for preparing 1-ethylol-2-methyl-5-nitroimidazole |
05/27/1992 | CA2096943A1 Oral spiramycine formulations and method for preparing same |
05/27/1992 | CA2074517A1 Methyl pyrrolidinone chitosan, production process and uses thereof |